Mydecine Innovations Group Inc. announced the appointment of John Ross as its Chief Financial Officer (CFO). Mydecine's board and management team are pleased to welcome John Ross, a senior financial management professional with more than 30 years of private and public company experience. He is currently the interim CEO (since May 2019) and CFO (Since February 2017) of Hempco Food and Fiber Inc., part time CFO of U3O8 Corp.

since June 2010, and part- time CFO of Buccaneer Gold Corp. (since September 2016).